Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. (PYRUS)

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: September 19, 2012
Last updated: June 18, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)